Alkermes Rises After Nektar Said To Explore Sale
February 02, 2018 at 16:12 PM EST
Shares of Alkermes have been rising this afternoon after Bloomberg reported that another drugmaker exploring some of the same therapeutic areas, Nektar Therapeutics, is exploring its strategic options, including a potential sale.